Opthea Ltd SEC filings CYVNY
Opthea Ltd has 204 filings in SEC EDGAR's recent list, going back to Jul 17, 2020. Its latest annual report, Form 20-F, was filed on Sep 15, 2025 for the period ended Jun 30, 2025. The most recent current report (Form 6-K) was filed on Nov 20, 2025. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 15F-12B | Filing | Nov 20, 2025 | — |
| 25 | Filing | Nov 10, 2025 | — |
| EFFECT | Filing | Feb 25, 2022 | — |
| CORRESP | Letter to the SEC | Feb 23, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2022 | — |
| EFFECT | Filing | Oct 16, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 15, 2020 | — |
| CORRESP | Letter to the SEC | Oct 15, 2020 | — |
| CORRESP | Letter to the SEC | Oct 15, 2020 | — |
| CERT | 8a cert | Oct 15, 2020 | — |
| 8-A12B | Filing | Oct 14, 2020 | — |
| CORRESP | Letter to the SEC | Oct 9, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 5, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 16, 2020 | — |
| DRSLTR | Filing | Sep 2, 2020 | — |
| DRS/A | Filing | Sep 2, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2020 | — |
| DRS | Filing | Jul 17, 2020 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CKDXF (OTC), CYVNY (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- South Yarra
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1815620
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.